Island receives Phase 2a/b dengue trial data
Island Pharmaceuticals says Phase 2a/b top-line results advocate for continued clinical development of ISLA-101 to treat dengue virus.
Island Pharmaceuticals says Phase 2a/b top-line results advocate for continued clinical development of ISLA-101 to treat dengue virus.
Tylah Tully chats with ClearVue CCO Earle Harper about the company’s solar façade technology and its role in the global push toward net-zero buildings.
Cochlear cites ongoing weakness in its service (sound processor) division as the key reason behind this morning’s full-year earnings downgrade.
AnteoTech’s life sciences business is poised to record a ~130% increase in FY2025 sales to $930,000 after receiving a sales order from the Serum Institute of India.
Biotech investors await the fallout from US Health Secretary RFK’s “extraordinary” move to sack all 17 members of a powerful vaccines panel.
Pure Hydrogen plans to spin-off its Windorah gas project into a new ASX-listed company have received a boost from the Queensland government.
Deal to make St Barbara a major shareholder of Geopacific Resources came ahead of the release of encouraging exploration results from its Woodlark Project in PNG.
EZZ Life Science inks three-year $21m distribution deal with ROFA Enterprises across three key Southeast Asian markets.
EZZ Life Science signs a 3 year, $21 million distribution deal with ROFA Enterprises to expand its presence in Southeast Asia.
Magmatic Resources’ second diamond hole at its Calais prospect in NSW has intersected both gold and copper mineralisation.
Codeifai has achieved a major commercial and development milestone with the launch of a new AI-driven URL shortener feature.
Codeifai’s ConnectQR.ai is now nearing 1000 subscribers since commercial launch in April, driven by its recent integration with Canva.
DXN’s $4.6m Hawaii win shows modular data centres are going mainstream. They’re faster, cheaper, and now firmly on investor radars.
Guy Le Page looks at Aura Energy’s acceleration heading into the development phase of its Tiris uranium project in Mauritania.
Original URL: https://www.themercury.com.au/business/stockhead/page/8